BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 22516942)

  • 1. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to treat protein-losing enteropathy.
    Rychik J; Spray TL
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():3-11. PubMed ID: 11994860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation.
    Ohuchi H; Yasuda K; Miyazaki A; Kitano M; Sakaguchi H; Yazaki S; Tsuda E; Yamada O
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):e49-57. PubMed ID: 23396878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation.
    Ono S; Ohuchi H; Miyazaki A; Yamada O
    Pediatr Cardiol; 2018 Oct; 39(7):1290-1298. PubMed ID: 29789917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
    Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low pulmonary vascular compliance predisposes post-Fontan patients to protein-losing enteropathy.
    Yu JJ; Yun TJ; Yun SC; Im YM; Lee SC; Shin HJ; Ko HK; Park JJ; Seo DM; Kim YH; Ko JK; Park IS
    Int J Cardiol; 2013 May; 165(3):454-7. PubMed ID: 21944467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
    Ostrow AM; Freeze H; Rychik J
    Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-Losing Enteropathy and Plastic Bronchitis After the Fontan Operation.
    Peyton C
    Crit Care Nurse; 2018 Dec; 38(6):e5-e12. PubMed ID: 30504504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Early Glenn Operation May be Associated with the Later Occurrence of Protein-Losing Enteropathy in Fontan Patients : Association of Early Glenn and Failing Fontan.
    Unseld B; Stiller B; Borth-Bruhns T; du Bois F; Kroll J; Grohmann J; Fleck T
    Pediatr Cardiol; 2017 Aug; 38(6):1155-1161. PubMed ID: 28534240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
    Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
    Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group.
    Mertens L; Hagler DJ; Sauer U; Somerville J; Gewillig M
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1063-73. PubMed ID: 9605076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-losing enteropathy after fontan surgery: is assessment of risk patients with immunological data possible?
    Lenz D; Hambsch J; Schneider P; Tárnok A
    Cytometry B Clin Cytom; 2003 May; 53(1):34-9. PubMed ID: 12717689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure.
    Yetman AT; Everitt MD
    Congenit Heart Dis; 2011; 6(4):370-3. PubMed ID: 21392262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone.
    Grattan MJ; McCrindle BW
    Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Impact of Fontan Operation on Enteric Protein Loss.
    Patel JK; Loomes KM; Goldberg DJ; Mercer-Rosa L; Dodds K; Rychik J
    Ann Thorac Surg; 2016 Mar; 101(3):1025-30. PubMed ID: 26652137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
    John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
    Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome.
    Silvilairat S; Cabalka AK; Cetta F; Grogan M; Hagler DJ; O'Leary PW
    Congenit Heart Dis; 2008; 3(4):262-8. PubMed ID: 18715460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-Losing Enteropathy Following Fontan Palliation.
    Al Balushi A; Mackie AS
    Can J Cardiol; 2019 Dec; 35(12):1857-1860. PubMed ID: 31711823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.